All blog posts
Showing 12 out of 91 results
16 6월 2026
2026 sees China's biotech scene continuing its ascent – but could US developments mean clouds on the horizon?
27 4월 2026
The EU Pharma Package is finally here – here's the settled position on key areas
12 3월 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
15 12월 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
09 12월 2025
Preserving the status quo: Boehringer Ingelheim awarded interim injunction
15 10월 2025
Venture investment in life sciences – Activity update & outlook (US & Europe)
24 9월 2025
Biopharma M&A activity – strategics continue to lead the way
28 8월 2025
The Thursday Investment Club: The case for later living
18 8월 2025
Pharma remains an enforcement focus in China – SAMR orders unwinding of a completed pharma deal
31 7월 2025
EU Regulatory Reform for Medicinal Products: Bolar exemption
22 7월 2025
Overview of EU regulatory and competition law in the Pharma sector
13 5월 2025
EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency
Showing 12 out of 91 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London